Dose-Dependent Development of Depressive Symptoms During Adjuvant Interferon-α Treatment of Patients With Malignant Melanoma-Reference-Cited by-同舟云学术

Dose-Dependent Development of Depressive Symptoms During Adjuvant Interferon-α Treatment of Patients With Malignant Melanoma

Published:2010-11 Issue:6 Volume:51 Page:466-473
ISSN:0033-3182
Container-title:Psychosomatics
language:en
Short-container-title:Psychosomatics

Author:

Friebe Astrid,Horn Martin,Schmidt Folkhart,Janssen Gesa,Schmid-Wendtner Monika-H.,Volkenandt Matthias,Hauschild Axel,Goldsmith Charlie H.,Schaefer Martin

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Applied Psychology,Arts and Humanities (miscellaneous)

Reference27 articles.

1. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group trial;Kirkwood;EST 1684. J Clin Oncol,1996

2. Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma: Austrian Malignant Melanoma Cooperative Group;Pehamberger;J Clin Oncol,1998

3. Superior survival of young women with malignant melanoma;Kemeny;Am J Surg,1998

4. Adjuvant interferon-α in malignant melanoma: current status;Hancock;Cancer Treat Rev,2000

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of Connexin 36 attenuates HMGB1‐mediated depressive‐like behaviors induced by chronic unpredictable mild stress;Brain and Behavior;2022-01-28

2. Evolution and Emerging Trends in Depression Research From 2004 to 2019: A Literature Visualization Analysis;Frontiers in Psychiatry;2021-10-29

3. Assigning Clinical Significance and Symptom Severity Using the Zung Scales: Levels of Misclassification Arising from Confusion between Index and Raw Scores;Depression Research and Treatment;2018